San Francisco, 24
January, Cervical Cancer Treatment Market Size, Share & Trends Analysis
Report By Type (SCC, Adenocarcinoma), By Product (Prevention, Treatment), By
Distribution Channel (Online, Hospital Pharmacies), And Segment Forecasts, 2018
– 2025.
The global cervical cancer treatment market size
is expected to reach USD 10.6 billion by 2025, according to a new report by
Grand View Research, Inc. The market is projected to record a CAGR of 5.0% over
the forecast period. Increased treatment penetration and rising disease
incidence are projected to drive the market growth over the next few years.
Although, sexually transmitted HPV is a major cause, the disease can also be
triggered by other factors, such as oral contraceptives, multiple sexual
partners, smoking, and HIV infection. There are more than 100 strains of HPV,
13 of which are high-risk or cancerous. Squamous cell carcinoma is the most
common type and it accounts for nearly 85% of the overall cases.
The differentiation between
squamous cell carcinoma and adenocarcinoma is based on the histology, as
observed under the microscope. Cervical adenosquamous carcinoma is rare,
involving a mixture of squamous and glandular tissues. Products for cervical
cancer can be broadly classified into prevention and treatment. Preventive
options involve vaccines against HPV. Currently, there are two commercial
vaccines – Gardasil and Cervarix. Treatment options include biologics, such as
Avastin and generics like topotecan, cisplatin, bleomycin, fluorouracil,
paclitaxel, carboplatin, and doxorubicin. The development of targeted
therapeutics with improved efficacy and reduced cost remains a key unmet need
of this market. Nevertheless, expanding focus on the research and development
in oncology, including cervical cancer, indicate a promising future for this
market.
Access Full Research
Report On Cervical Cancer Treatment Market Analysis:
Further key findings from the study suggest:
·
HPV affects nearly 95% of all
cervical cancer cases. HPV strains 16 and 18 account for nearly 70% of all
cases reported
·
Nearly three-fourth of all
cases occur in developing and underdeveloped regions (mostly, in Asia and
Africa), where healthcare facilities are limited and awareness about diagnosis
and treatment is low
·
North America was the dominant
region in the global cervical cancer treatment market and is expected to
continue its dominance over the estimated period
·
This growth is attributed to
growing target population patient, increasing market penetration of drugs, and
easy accessibility to advanced treatments
·
Some of the key companies in
the market include F. Hoffmann-LA Roche AG; Merck & Co., Inc.;
GlaxoSmithKline PLC; Allergan PLC; Pfizer, Inc.; Biocon Ltd.; Bristol-Myers
Squibb Company; AstraZeneca PLC; and Eli Lilly & Co.
·
Merck & Co. led the
competitive space and is likely to continue to be the largest shareholder due
to strong commercial performances of Gardasil and Keytruda
Browse More Reports Of This Category By
Grand View Research At: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the
global cervical cancer treatment market on the basis of type, product,
distribution channel, and region:
Cervical Cancer Treatment Type
Outlook (Revenue, USD Million, 2014 - 2025)
·
Squamous Cell Carcinoma (SCC)
·
Adenocarcinoma
·
Adenosquamous Carcinoma
Cervical Cancer Treatment Product
Outlook (Revenue, USD Million, 2014 - 2025)
·
Prevention
o
Gardasil/Gardasil9
o
Cervarix
·
Treatment
o
Avastin
o
Keytruda
o
Generics
o
Others
Cervical Cancer Treatment Distribution
Channel Outlook (Revenue, USD Million, 2014 - 2025)
·
Hospital Pharmacies
·
Retail Pharmacies
·
Online Pharmacies
Cervical Cancer Treatment Regional
Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
U.K.
o
Germany
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
Access Full Press
Release of this Report:
www.grandviewresearch.com/press-release/global-cervical-cancer-treatment-market
www.grandviewresearch.com/press-release/global-cervical-cancer-treatment-market
About Grand View
Research
Grand View Research, Inc.
is a U.S. based market research and consulting company, registered in the State
of California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For more information:
www.grandviewresearch.com/
No comments:
Post a Comment